Literature DB >> 6885983

Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii.

H L Muytjens, H C Zanen, H J Sonderkamp, L A Kollée, I K Wachsmuth, J J Farmer.   

Abstract

Eight cases of neonatal meningitis due to Enterobacter sakazakii (formerly known as yellow-pigmented Enterobacter cloacae) which occurred in The Netherlands during the last 6 years were investigated retrospectively. Two patients had necrotizing enterocolitis and meningitis simultaneously. Despite treatment (in most cases with ampicillin and gentamicin), the fatality rate was 75%. Strains were much more susceptible to some of the new beta-lactam antibiotics than to ampicillin. A mode of transmission other than passage through the birth canal was likely, at least for some patients. A cluster of four patient strains in one hospital had almost identical plasmid DNA profiles. However, two strains isolated from formula at the same hospital 2 days after the onset of one case had different profiles, as did the strains from patients in other hospitals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885983      PMCID: PMC270753          DOI: 10.1128/jcm.18.1.115-120.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Neonatal death from pigmented coliform infection.

Authors:  A M URMENYI; A W FRANKLIN
Journal:  Lancet       Date:  1961-02-11       Impact factor: 79.321

2.  Ventriculitis complicating meningitis.

Authors:  J H Salmon
Journal:  Am J Dis Child       Date:  1972-07

3.  Intraventricular use of aminoglycosides in the treatment of gram-negative bacillary meningitis: conflicting views.

Authors:  M N Swartz
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

4.  Neonatal meningitis due to Enterobacter sakazakii.

Authors:  H L Muytjens; L A Kollée
Journal:  Tijdschr Kindergeneeskd       Date:  1982-08

5.  Necrotizing enterocolitis. Epidemic following an outbreak of Enterobacter cloacae type 3305573 in a neonatal intensive care unit.

Authors:  J Powell; M A Bureau; C Paré; M L Gaildry; D Cabana; H Patriquin
Journal:  Am J Dis Child       Date:  1980-12

6.  Oral gentamicin therapy in the prevention of neonatal necrotizing enterocolitis. A controlled double-blind trial.

Authors:  L J Grylack; J W Scanlon
Journal:  Am J Dis Child       Date:  1978-12

7.  Meningoencephalitis and compartmentalization of the cerebral ventricles caused by Enterobacter sakazakii.

Authors:  M B Kleiman; S D Allen; P Neal; J Reynolds
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

8.  Bacteremia associated with Enterobacter sakazakii (yellow, pigmented Enterobacter cloacae).

Authors:  P W Monroe; W L Tift
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

9.  Neonatal necrotizing enterocolitis: a nine-year experience.

Authors:  R M Kliegman; A A Fanaroff
Journal:  Am J Dis Child       Date:  1981-07

10.  Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.

Authors:  U B Schaad; G H McCracken; N Threlkeld; M L Thomas
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

View more
  57 in total

1.  Fluorogenic selective and differential medium for isolation of Enterobacter sakazakii.

Authors:  Se-Wook Oh; Dong-Hyun Kang
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

2.  Characterization of putative virulence genes on the related RepFIB plasmids harbored by Cronobacter spp.

Authors:  A A Franco; L Hu; C J Grim; G Gopinath; V Sathyamoorthy; K G Jarvis; C Lee; J Sadowski; J Kim; M H Kothary; B A McCardell; B D Tall
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

3.  Effectiveness of disinfectants in killing Enterobacter sakazakii in suspension, dried on the surface of stainless steel, and in a biofilm.

Authors:  Hoikyung Kim; Jee-Hoon Ryu; Larry R Beuchat
Journal:  Appl Environ Microbiol       Date:  2006-12-15       Impact factor: 4.792

4.  Distribution and antibiotic susceptibility of extraintestinal clinical isolates of Klebsiella, Enterobacter and Serratia species.

Authors:  P E Varaldo; F Biavasco; S Mannelli; R Pompei; A Proietti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

5.  Quality of powdered substitutes for breast milk with regard to members of the family Enterobacteriaceae.

Authors:  H L Muytjens; H Roelofs-Willemse; G H Jaspar
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

Review 6.  Use of plasmid profiles in epidemiologic surveillance of disease outbreaks and in tracing the transmission of antibiotic resistance.

Authors:  L W Mayer
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

7.  Enzymatic profiles of Enterobacter sakazakii and related species with special reference to the alpha-glucosidase reaction and reproducibility of the test system.

Authors:  H L Muytjens; J van der Ros-van de Repe; H A van Druten
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

Review 8.  Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis.

Authors:  Claudia N Emami; Mikael Petrosyan; Stefano Giuliani; Monica Williams; Catherine Hunter; Nemani V Prasadarao; Henri R Ford
Journal:  Surg Infect (Larchmt)       Date:  2009-10       Impact factor: 2.150

9.  Isolation of Cronobacter spp. (formerly Enterobacter sakazakii) from infant food, herbs and environmental samples and the subsequent identification and confirmation of the isolates using biochemical, chromogenic assays, PCR and 16S rRNA sequencing.

Authors:  Ziad W Jaradat; Qotaiba O Ababneh; Ismail M Saadoun; Nawal A Samara; Abrar M Rashdan
Journal:  BMC Microbiol       Date:  2009-10-27       Impact factor: 3.605

10.  Multilocus sequence typing of Cronobacter sakazakii and Cronobacter malonaticus reveals stable clonal structures with clinical significance which do not correlate with biotypes.

Authors:  Adam Baldwin; Michael Loughlin; Juncal Caubilla-Barron; Eva Kucerova; Georgina Manning; Christopher Dowson; Stephen Forsythe
Journal:  BMC Microbiol       Date:  2009-10-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.